Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database

• Published in: Journal of surgical oncology Vol. 121; no. 7; pp. 1097 - 1103
• Main Authors: Malik, Azeem T., Baek, Jae, Alexander, John H., Voskuil, Ryan T., Khan, Safdar N., Scharschmidt, Thomas J.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.06.2020
• Subjects: Adolescent; Adult; Aged; Bone cancer; Bone Neoplasms - mortality; Bone Neoplasms - pathology; bone sarcoma; Databases, Factual; Female; Histiocytoma, Malignant Fibrous - mortality; Histiocytoma, Malignant Fibrous - pathology; Humans; Kaplan-Meier Estimate; Male; malignant fibrous histiocytoma; Medical prognosis; Medicare; MFH; Middle Aged; Mortality; NCDB; Proportional Hazards Models; Retrospective Studies; Sarcoma; survival; Survival analysis; undifferentiated pleomorphic sarcoma; United States - epidemiology; UPS; Young Adult; United States; malignant fibrous histiocytoma; undifferentiated pleomorphic sarcoma; NCDB; survival; UPS; MFH; bone sarcoma
• ISSN: 0022-4790; 1096-9098
• DOI: 10.1002/jso.25878

Background and Objectives Malignant fibrous histiocytoma (MFH) of bone, now known as undifferentiated pleomorphic sarcoma of bone, is a rare neoplasm that accounts for less than 2% of all primary malignant bone tumors. The objective of the current study was to evaluate prognosis and survival for MFH of bone. Methods The 2004 to 2016 National Cancer Database was queried to identify patients with a primary MFH of bone. Kaplan‐Meier survival and Cox regression analyses were used to analyze overall survival and risk factors associated with overall mortality. Results The overall 5‐year and 10‐year survival rates were 38.3% and 30.5%, respectively. Increasing stage and metastatic disease at presentation were associated with poor overall survival (P < .001). Patients aged 18 to 50 years (hazard ratio [HR], 0.51), 51 to 75 years (HR, 0.61), and those undergoing surgery (HR, 0.39) had improved survival. Having Medicare insurance (HR, 1.48), residing in a low educated area (HR, 2.56), and positive surgical margins (HR, 1.80) were associated with poor survival. Conclusions The overall prognosis of MFH of bone is poor with a reported 5‐year survival rate of 38.3%. Undergoing surgery and younger age were associated with a better prognosis. Older age, having Medicare insurance, and positive surgical margins were predictors of mortality.